About GPC Biotech
GPC Biotech is a company based in Planegg (Germany) founded in 1997. GPC Biotech offers products and services including Hondatoto App, Togel Games, and Slots and Casino. GPC Biotech operates in a competitive market with competitors including Jazz Pharmaceuticals, Horizon Discovery, C4 Therapeutics, Erasca and Revolution Medicines, among others.
- Headquarter Planegg, Germany
- Stage Public
- SectorsHealthcare
- Website gpc-biotech.com
- Social LinkedIn
- Latest Funding Round$1.4M (USD), Grant
Jun 2007
- Investors
Products & Services of GPC Biotech
GPC Biotech offers a comprehensive portfolio of products and services, including Hondatoto App, Togel Games, and Slots and Casino.
App for downloading and playing online togel games securely.
Various pools like Macau and Singapore for number betting.
Online slots and live casino games for entertainment betting.
Funding Insights of GPC Biotech
- Total Rounds 2
- Last Round Grant — $1.4M
- First Round $43.1M
(Feb 2006)
- Investors Count 1
All 2 funding rounds of GPC Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | $1.4M | Grant | – | – | |
| Feb 2006 | $43.1M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in GPC Biotech
GPC Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BMBF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Education and research policies are overseen by the ministry. | 1955 | bmbf.de | Berlin, Germany |
Investor details for GPC Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GPC Biotech
4 dated milestones of GPC Biotech across 10 years, from founding to its latest funding, stage changes and deals.
- Founded GPC Biotech is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $43.1M.
- Funding Latest funding round, Grant, of $1.4M.
Competitors of GPC Biotech
GPC Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Horizon Discovery, C4 Therapeutics, Erasca and Revolution Medicines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| jazzpharma.com | 2003 | Dublin, Ireland | $265M | 2,800 | Novel biopharmaceutical medicines are developed for unmet medical needs. | |
| horizondiscovery.com | 2007 | Cambridge, United Kingdom | $46.29M | 432 | Genetically modified cell lines are developed using AAV gene-editing platform. | |
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. | |
| miragen.com | 2007 | Boulder, United States | $111.29M | 92 | MicroRNA-based therapeutics are developed for treating multiple diseases. | |
| mereobiopharma.com | 2015 | London, United Kingdom | $119M | 56 | Therapeutics for cancer and rare diseases are developed. |
Detailed competitors of GPC Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gpc Biotech
Complete news archive for GPC Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to GPC Biotech
10 companies that operate in the same segment as GPC Biotech (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GPC Biotech
GPC Biotech was founded in 1997 and raised its 1st funding round 9 years after it was founded.
GPC Biotech is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
GPC Biotech was founded in 1997 in Planegg, Germany, as a biopharmaceutical company. Operations centered on oncology, with a pipeline featuring Satraplatin, a platinum-based molecule in phase 3 trials for hormone-refractory prostate cancer, and a monoclonal antibody in phase 1 for relapsedrefractory B-cell lymphoma. Acquisition by Agennix took place in 2009, concluding independent development activities.
GPC Biotech's top competitors include Jazz Pharmaceuticals, Horizon Discovery and C4 Therapeutics.
GPC Biotech offers Hondatoto App, Togel Games, and Slots and Casino.
GPC Biotech has 1 investor. Key investors include BMBF.